Pfmdr1 and in vivo resistance to artesunate-mefloquine in falciparum malaria on the Cambodian-Thai border.
about
Declining artesunate-mefloquine efficacy against falciparum malaria on the Cambodia-Thailand borderPfmdr1 copy number and arteminisin derivatives combination therapy failure in falciparum malaria in CambodiaRapid Diagnosis of MalariaArtemisinin Resistance in Plasmodium falciparum MalariaGametocyte clearance dynamics following oral artesunate treatment of uncomplicated falciparum malaria in Malian childrenArtemisinin-based combination therapies: a vital tool in efforts to eliminate malariaMarine actinomycetes: a new source of compounds against the human malaria parasiteA research agenda for malaria eradication: drugsIn vitro sensitivity of Plasmodium falciparum from China-Myanmar border area to major ACT drugs and polymorphisms in potential target genesThe role of Pfmdr1 and Pfcrt in changing chloroquine, amodiaquine, mefloquine and lumefantrine susceptibility in western-Kenya P. falciparum samples during 2008-2011A new in vivo screening paradigm to accelerate antimalarial drug discoveryPlasmodium falciparum Resistance to Artemisinin Derivatives and Piperaquine: A Major Challenge for Malaria Elimination in Cambodia.World Antimalarial Resistance Network (WARN) III: molecular markers for drug resistant malaria.Molecular surveillance for drug-resistant Plasmodium falciparum in clinical and subclinical populations from three border regions of Burma/Myanmar: cross-sectional data and a systematic review of resistance studiesFailure of artesunate-mefloquine combination therapy for uncomplicated Plasmodium falciparum malaria in southern CambodiaHemoglobin cleavage site-specificity of the Plasmodium falciparum cysteine proteases falcipain-2 and falcipain-3.The clinical impact of artemisinin resistance in Southeast Asia and the potential for future spread.Resistance to antimalarial drugs: molecular, pharmacologic, and clinical considerations.pfmdr1 amplification and fixation of pfcrt chloroquine resistance alleles in Plasmodium falciparum in Venezuela.Laboratory detection of artemisinin-resistant Plasmodium falciparumRole of pfmdr1 amplification and expression in induction of resistance to artemisinin derivatives in Plasmodium falciparum.Monitoring for Plasmodium falciparum drug resistance to artemisinin and artesunate in Binh Phuoc Province, Vietnam: 1998-2009.Validating a firefly luciferase-based high-throughput screening assay for antimalarial drug discovery.Measuring the efficacy of anti-malarial drugs in vivo: quantitative PCR measurement of parasite clearanceFive-year tracking of Plasmodium falciparum allele frequencies in a holoendemic area with indistinct seasonal transitions.High prevalence of pfmdr1 N86Y and Y184F mutations in Plasmodium falciparum isolates from Bioko Island, Equatorial GuineaIn vivo parasitological measures of artemisinin susceptibilityMultiple genetic backgrounds of the amplified Plasmodium falciparum multidrug resistance (pfmdr1) gene and selective sweep of 184F mutation in CambodiaDried whole-plant Artemisia annua slows evolution of malaria drug resistance and overcomes resistance to artemisinin.Orally formulated artemisinin in healthy fasting Vietnamese male subjects: a randomized, four-sequence, open-label, pharmacokinetic crossover studyEfficacy and pharmacokinetic evaluation of a novel anti-malarial compound (NP046) in a mouse model.Plasmodium falciparum isolates from southern Ghana exhibit polymorphisms in the SERCA-type PfATPase6 though sensitive to artesunate in vitro.Polymorphisms of molecular markers of antimalarial drug resistance and relationship with artesunate-mefloquine combination therapy in patients with uncomplicated Plasmodium falciparum malaria in Thailand.Decreasing pfmdr1 copy number suggests that Plasmodium falciparum in Western Cambodia is regaining in vitro susceptibility to mefloquineMonitoring the efficacy of artemether-lumefantrine for the treatment of uncomplicated malaria in Malawian children.Prevalence of single nucleotide polymorphisms in the Plasmodium falciparum multidrug resistance gene (Pfmdr-1) in Korogwe District in Tanzania before and after introduction of artemisinin-based combination therapy.Selection and spread of artemisinin-resistant alleles in Thailand prior to the global artemisinin resistance containment campaignPhenotypic and genotypic analysis of in vitro-selected artemisinin-resistant progeny of Plasmodium falciparumIn vivo antimalarial evaluation of some 2,3-disubstituted-4(3H)-quinazolinone derivatives.No evidence of delayed parasite clearance after oral artesunate treatment of uncomplicated falciparum malaria in Mali.
P2860
Q21032539-6A5A00DD-A347-4B0E-8E45-A5C6B1E05C2BQ21034146-F5EC7FE6-36E5-4FCA-B427-E5014F94C059Q21342775-13CCE9AB-C167-4097-B3C2-C09405A5FEBEQ22061852-C537C746-1866-4465-B3D2-3257B7C9BADDQ22773191-8A45BF22-283B-426D-80F2-F708BC875E8BQ24614989-5957E4B8-50AE-4B7E-B8D1-4AE0C1A47503Q28472855-DF1E95A8-D857-4A00-8969-673AEED75368Q28476806-7CBE6F8E-0BDF-43C2-944F-840E26D7C61EQ28484068-D327E5E4-DFD3-456A-AB5F-2CBD65280F03Q28487960-A2FD9DC9-8E5F-4680-A7FE-4102F8701F2AQ28534314-DA079FA1-59C3-4C86-8139-9A60B5CE43E7Q30240158-202D5D03-715A-4A36-A87A-DAA29A0AF57EQ30483555-2DB313DA-F574-4668-AAC4-5AFF9799CB58Q30568502-455FED9E-C262-4DA9-8F07-8E743C01A740Q33399259-00027EDD-A92C-46D6-A8D1-B062C0E546DBQ33428555-3B0FF75B-9280-4096-B0CB-420D8F13A02AQ33655603-72D1A5F6-E647-4333-8F1F-23D514255ABDQ33723453-616C26B6-8E5A-40E2-A837-93723C03CE6FQ33768885-3B8BA0C8-7C16-440C-87E0-CECA3597C782Q33798139-06A8B55F-C223-4440-BCC8-3ED19ECA76C5Q33876651-4BEA9DBB-778D-45D4-A9BD-36AF58734049Q33998183-DCD6E19B-B5BE-449A-BBD3-A1D1B2BE0349Q34066061-08D9099A-B1C6-4982-BB1F-E08BEBA07B9BQ34351109-B2B5F94E-6699-4B33-96A6-FEFA70C855B5Q34488950-46DF8F66-ECF9-4A3B-B426-8335ADE89A8BQ34562754-B5C4D324-855B-4743-89C3-C0B21446C0ACQ34921155-740CF6F9-4D6A-445A-8E45-5330F98761F0Q34986023-A50BEE66-E31A-4405-A1BE-81335178A86DQ35031523-9F808663-20E7-402B-921E-8B2D7DF82800Q35056250-F6B3806C-9CE7-4346-ADC5-200D42AB3A15Q35079191-78982FB7-DBFD-4EDF-9F3E-0011027344BFQ35137475-8E12A944-9FEF-4A46-B0BE-E59DA401554CQ35186886-326323A6-2550-4DC7-8F15-5EC4E623BB39Q35385674-F86D6442-2190-4C48-B4B9-4A6B9F923835Q35538818-BA9E5864-CCBD-4E57-B3E6-8C037ACBB9D3Q35576130-8C21234D-A2B0-4F50-AACF-8E3E52A98898Q35594027-133B89A3-1EE0-4159-A5B8-6937D737E3E7Q35666578-057F9064-A5A7-48D3-8EB2-A6364A4DEB11Q35815377-9111CACB-E45A-48F8-935D-60325732BD52Q36080109-6620CDBA-F6C9-4E93-BA87-982E714F8482
P2860
Pfmdr1 and in vivo resistance to artesunate-mefloquine in falciparum malaria on the Cambodian-Thai border.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Pfmdr1 and in vivo resistance ...... on the Cambodian-Thai border.
@en
Pfmdr1 and in vivo resistance ...... on the Cambodian-Thai border.
@nl
type
label
Pfmdr1 and in vivo resistance ...... on the Cambodian-Thai border.
@en
Pfmdr1 and in vivo resistance ...... on the Cambodian-Thai border.
@nl
prefLabel
Pfmdr1 and in vivo resistance ...... on the Cambodian-Thai border.
@en
Pfmdr1 and in vivo resistance ...... on the Cambodian-Thai border.
@nl
P2093
P921
P1476
Pfmdr1 and in vivo resistance ...... on the Cambodian-Thai border.
@en
P2093
Alisa P Alker
Chansuda Wongsrichanalai
Denis Mey Bouth
Frederic Ariey
Jason D Maguire
Naman K Shah
Pharath Lim
Poravuth Yi
Reiko Tsuyuoka
P304
P407
P577
2007-04-01T00:00:00Z